Tag Archives: Monkeypox

Monkeypox Declared a Public Health Emergency, by Dr. Joseph Mercola

Serial pandemics have arrived. Next on the fear agenda: monkeypox. From Dr. Joseph Mercola at theburningplatform.com:

Story at-a-glance

  • By the third week of July 2022, some 16,000 cases of monkeypox had been recorded across 75 countries, with the vast majority of cases occurring among homosexual and bisexual men. In the U.S., recorded cases were around 3,000, including two children
  • July 23, 2022, World Health Organization Director-General Tedros Adhanom Ghebreyesus unilaterally overruled this panel of advisers and declared monkeypox a “public health emergency of international concern” (PHEIC). Ghebreyesus made the decision to declare a PHEIC even though the WHO’s advisory panel opposed the declaration 9 to 6
  • According to Ghebreyesus, “for the moment this is an outbreak that is concentrated among men who have sex with men, especially those with multiple sexual partners. That means that this is an outbreak that can be stopped with the right strategies in the right groups”
  • At present, the PHEIC appears to be financially motivated. Moderna is testing an mRNA injection for monkeypox, and in addition to the two smallpox vaccines already approved, Aventis Pasteur also has a smallpox vaccine that, while still investigational, could receive emergency use authorization
  • Disturbingly, in February 2022, the Wuhan Institute of Virology published a study in which they describe creating a portion of a monkeypox genome from scratch in order to develop a PCR test for monkeypox diagnosis. The National Institutes for Health in the U.S. also began studying a monkeypox drug in 2020

Continue reading→

We’re “losing the fight against monkeypox”…apparently, by Kit Knightly

It’s clear that monkeypox is already a global scourge. There’s been around 8000 cases and 3 reported deaths. Needless to say, all the usual mainstream media suspects are giving it full coverage. From Kit Knightly at off-guardian.org:

According to the New York Times the US is currently “losing the fight with Monkeypox”. That’s probably news to you.

After all, given the fact the US has around 700 cases of Monkeypox (around 0.0002% of the population), that the entire world only 8000 “cases” (about 0.0001%), and that there have been just 3 reported deaths…well, you’d be forgiven for not realising there was a fight at all, let alone that we were losing.

It’s really more of a kerfuffle. At worst. Perhaps a fracas.

That is – of course – assuming there is any monkeypox “outbreak” at all, something we should never take on faith, especially in the post-Covid world.

Nevertheless, the NYT is sure…

There probably will be many more infections before the outbreak can be controlled, if at this point it can be controlled at all.

Continue reading→

Ape Fever? By Eric Peters

From now on there will always be a pandemic and governments will use each one to increase their power at the expense of the people. From Eric Peters at ericpetersautos.com:

That’s probably next – after Monkey Pox, which is shaping up to be the next excuse for re-opening the World Hospital, in which we’re all to be admitted as involuntary patients.

The pox – which will be on us – is said to have been spreading among us. Sweden’s gesundheitsfuhrers have already declared it a “danger to public health” that could “justify new restrictions.” Belgium just announced actual restrictions – including a “mandatory” (that word, again) 21-day quarantine for those suspected of being Monkey Poxxers. And the World Health Organization – which seeks to “organize” the world using assertions about sickness as its justification for doing just that  – has called an “emergency meeting” about the pox.

We can safely assume what comes next.

Continue reading→ 

Monkeypox Was a Table-Top Simulation Only Last Year, by Michael Senger

A new pandemic is arriving right on schedule. From Michael Senger at brownstone.org:

Elite media outlets around the world are on red alert over the world’s first-ever global outbreak of Monkeypox in mid-May 2022—just one year after an international biosecurity conference in Munich held a simulation of a “global pandemic involving an unusual strain of Monkeypox” beginning in mid-May 2022.

Monkeypox was first identified in 1958, but there’s never been a global Monkeypox outbreak outside of Africa until now—in the exact week of the exact month predicted by the biosecurity folks in their pandemic simulation. Take these guys to Vegas!

Ed Yong, who’s penned dozens of hysterical articles on Covid for The Atlantic including such gems as COVID-19 Long-Haulers Are Fighting for Their FutureEven Health-Care Workers With Long COVID Are Being DismissedHow Did This Many Deaths Become Normal? and The Final Pandemic Betrayal, is hot on the scene of the new Monkeypox outbreak.

Continue reading→

Monkeypox Fears May Rescue Endangered Corporations, by Whitney Webb

The emerging monkeypox replacement for Covid features the same type of corrupt public-private partnerships as Covid. From Whitney Webb at unlimitedhangout.com:

Two corrupt companies were in rocky financial territory just a few weeks ago. Now, with concerns over a global monkeypox outbreak being hyped by media and global health organizations alike, the worries – and sins – of these two firms are quickly being forgotten

In recent days, concern over a global outbreak of monkeypox, a mild disease related to smallpox and chickenpox, has been hyped in the media and health ministries around the world, even prompting an emergency meeting at the World Health Organization (WHO). For some, fears have centered around monkeypox being the potential “next pandemic” after Covid-19. For others, the fear is that monkeypox will be used as the latest excuse to further advance draconian biosecurity policies and global power grabs.

Regardless of how the monkeypox situation plays out, two companies are already cashing in. As concern over monkeypox has risen, so too have the shares of Emergent Biosolutions and SIGA Technologies. Both companies essentially have monopolies in the US market, and other markets as well, on smallpox vaccines and treatments. Their main smallpox-focused products are, conveniently, also used to protect against or treat monkeypox as well. As a result, the shares of Emergent Biosolutions climbed 12% on Thursday, while those of SIGA soared 17.1%.

Continue reading→